ABSTRACT Background Epidemiological evidence has confirmed that periodontitis is an essential and independent risk factor of chronic obstructive pulmonary disease (COPD). Porphyromonas gingivalis, a major pathogen implicated in periodontitis, may make a vital contribution to COPD progression. However, the specific effects and molecular mechanism of the link between P. gingivalis and COPD are not clear. Methods and Results A COPD rat model was constructed by smoke exposure combined intratracheal instillation of E. coli-LPS, then P. gingivalis was introduced into the oral cavity of COPD rats. This research observed that lower lung function, more severe alveolar damage and inflammation occurred in COPD rats with P. gingivalis group. Meanwhile, P. gingivalis/gingipains could colonize the lung tissues and be enriched in bronchoalveolar lavage fluid (BALF) of COPD rats with P. gingivalis group, along with alterations in lung microbiota. Proteomic analysis suggested that Hsp90α/MLKL-meditated necroptosis pathway was up-regulated in P. gingivalis-induced COPD aggravation, the detection of Hsp90α and MLKL in serum and lung tissue verified that Hsp90α/MLKL was up-regulated. Conclusion These results indicate that P. gingivalis could emigrate into the lungs, alter lung microbiota and lead to aggravation of COPD, which Hsp90α/MLKL might participate in. KEYWORDS: Porphyromonas gingivalis, chronic obstructive pulmonary disease, lung microbiota, Hsp90α, MLKL, necroptosis Introduction As the main cause of tooth loss, periodontitis impairs people’s quality of life and is an essential and independent risk factor of chronic obstructive pulmonary disease (COPD) [[40]1,[41]2]. COPD is a common and chronic respiratory disease which is characterized by irreversible airflow limitation due to airway and/or alveolar abnormalities [[42]3]. Sometimes COPD patients suffer from severe exacerbations which is associated with significantly lower survival outcomes [[43]4,[44]5]. Poor periodontal health, especially higher plaque scores and fewer teeth, is associated with the increased frequency of exacerbations in COPD patients [[45]6]. Some researches focused on the involvement of periodontal pathogens in the development of COPD [[46]7–9]. Porphyromonas gingivalis, a major pathogens in periodontitis development, may play a crucial role in COPD progress [[47]10]. A prospective follow-up study found that COPD patients with high serum P. gingivalis IgG titers had significantly lower incidence and frequent of exacerbation than patients with normal IgG titers [[48]11]. Our previous studies also found a high detection rate of P. gingivalis in respiratory secretions of patients with COPD exacerbation, which is homologous to P. gingivalis in dental plaque, supported the hypothesis that P. gingivalis may contribute to the pathology of COPD exacerbation [[49]12]. However, the specific effects and molecular mechanism of the link between P. gingivalis and COPD are not clear. In healthy individuals, the lung microbiota is relatively simple and low in abundance that an ecological balance between lung microbiota and host was maintained through mechanical and immune clearance [[50]13]. However, there is a significant disruption of the lung microbiota, characterized by dysbiosis in microbial composition and quantity in COPD [[51]14,[52]15]. Multi-omics analysis found that the altered lung microbiome in COPD interact with host gene expression by their metabolites to promote inflammation [[53]16]. The changes in airway microbes also shift COPD from neutrophilic to eosinophilic inflammation [[54]17]. Pseudomonas aeruginosa and Streptococcus pneumoniae are common respiratory condition pathogens that may induce acute exacerbation of COPD [[55]18,[56]19]. P. gingivalis was known to enhance the adhesion of Streptococcus pneumoniae to alveoli by promoting the expression of Platelet-Activating Factor Receptor through gingipain [[57]20]. P. gingivalis or its virulence factors can also cooperate with Streptococcus pneumoniae and Pseudomonas aeruginosa to promote alveolar epithelial cell apoptosis and aggravate respiratory inflammation [[58]21,[59]22]. However, no study has reported the impact of P. gingivalis on lung microbiota in COPD progress. Inflammation is the main mechanism of COPD progression, which can lead to small airway damage, alveolus destruction, and lung function reduced [[60]23]. As a cytosolic molecular chaperone, Heat shocked protein 90 α (Hsp90α) could regulate the phosphorylation, oligomerization and membrane transport of Mixed Lineage Kinase Domain Like Pseudokinase (MLKL) [[61]24,[62]25]. Activated MLKL can translocate to the cell membrane, leading to plasma membrane rupture and cell necroptosis [[63]26]. With the rupture of the plasma membrane, cells swell, chromatin shrinks, and damaged cells release a significant quantity of damage associated molecular patterns (DAMPs), inflammatory factors and cellular contents which directly causing inflammation and indirectly spreading inflammatory responses [[64]27–29]. Early study has found that Hsp90α in serum of patients with moderate-to-severe COPD are significantly higher than those of healthy smokers and non-smoking controls [[65]30]. The expression of MLKL/p-MLKL protein is increased in respiratory epithelial cells and macrophages of patients with severe COPD [[66]31]. Therefore, Hsp90α/MLKL may participate in the occurrence and development of COPD. In the present study, by constructing COPD rat model and P. gingivalis inoculation in COPD rats’ oral cavity, we want to investigate the specific effects and molecular mechanism of the link between P. gingivalis and COPD. So as to clarify the role of P. gingivalis in COPD progression and provide a novel idea on the prevention and treatment of COPD. Materials and methods Bacterial cultures P. gingivalis W83 (Provided by the Department of Periodontology, School of Stomatology, China Medical University) were cultured in fresh brain heart infusion (BHI) agar plate with 0.5% hemin, 0.1% menadione (vitamin K1),0.05% yeast extract and 5% sterile defibrinated sheep blood at 37°C in an anaerobic jar for 3–5 days. Monoclonal colonies in good growth condition (dark black and shiny) were selected to BHI liquid medium without sheep blood. After 16–18 h culturation, bacteria were collected by centrifugation at 3500 rpm for 5 min, and resuspended in sterile PBS. OD was measured using a UV spectrophotometer at 600 nm, and 1 × 10 [[67]9] CFU/mL was used as the bacterial concentration at an absorbance of one. Animal model The Sprague-Dawley (SD) rats (180–200 g, 6–7 weeks-old) were purchased from Changsheng Biotechnology Co., Ltd. (Liaoning, China). After being fed adaptively in SPF laboratory animal room for 1 week, the rats were randomly divided into three groups (n = 6 per group): Control, COPD, COPD with P. gingivalis (COPD+P.g). The method of COPD rat modeling was minor modified according to some references [[68]32,[69]33]. Briefly,